Drug Delivery Partnerships 2012(药物传递·合作夥伴关系会议)
2012年1月25-27日 - 内华达州拉斯维加斯

时间和金钱一样贵重。必须有效使用金钱。您若想有最可靠的业绩,考虑将时间和钱花在有益的药物传递会议上,请勿错过Drug Delivery Partnerships(DDP)。再也找不到有提供想见的人和想听的内容之会议了。DDP有过去15年业绩,将成为与今后商务更加相连的内容。

DDP是全球最大的药物传递会议,为提高长期收益,以加速药剂上市及延长其生命周期为目的,是能找到新合夥人、药物传递技术和新处方设计开发策略的机会。

SUBMIT YOUR PROPOSAL NOW!
The Institute for International Research is looking for papers for its upcoming 16th Annual Drug Delivery Partnerships Conference, to be held on January 25-27th, 2012 in Las Vegas, NV at the Caesar's Palace hotel. This meeting sets the stage for accelerated pharmaceutical innovation in the drug delivery space by being the meeting place to find strategic partnerships to get drugs to market cheaper and faster and ensure prolonged lifecycles.

Choose your language
Japanese
Korean

创新奖(innovation award)
Drug Delivery Partnerships Products of the Year awards Ceremony(药物传递合作产品年度授赏典礼)中,授予今年有最创新活动的科学家这个奖。
是医药品业界最大且最长的活动,作为深受好评的药物传递会议,今年亦举行最好且有益的活动。
2012年的DDP Awards category
award image
技术创新
出色的合作
业界的伟业
关注的"企业
产业会议汇总历
Submission Guidelines & Details
In your abstract, please provide the following:

Proposed Title of Session: Objective and purpose
  • A descriptive paragraph of 3-4 sentences describing what is unique or special about the information you plan to share- aka Background Information
  • 3-4 bullet points highlighting the game changing strategies, tools and techniques attendees will walk away with- aka Key Takeaways
We are currently recruiting drug delivery and formulation executives who can share NEW DATA through detailed case studies related to leveraging the value of drug formulation and delivery to improve product pipelines, patient outcomes and boost innovation. Some of the categories of topics are:
  • Drug delivery partnerships as a strategy for pipeline value creation
  • Lessons learned to overcome biologic stability and manufacturing issues
  • Re-formulation for life cycle management
  • Innovation for OTC drugs
  • Marketplace opportunities for biosimilars
  • Regional preference for drug delivery methodologies in emerging markets
  • Current landscape for nanoparticles as drug carriers
  • Current reimbursement roadmap
***This list is merely suggestive, not comprehensive nor obligatory.
Do you want to reach this audience?
We have a limited number of slots available for solution providers/consultants.

© 2009-2010 IIR Holdings, LTD. All Rights Reserved.
营运 : Institute for International Research (IIR)代理商 日商环球讯息有限公司